163 related articles for article (PubMed ID: 2113031)
21. Is thioredoxin the physiological vitamin K epoxide reducing agent?
Preusch PC
FEBS Lett; 1992 Jul; 305(3):257-9. PubMed ID: 1299627
[TBL] [Abstract][Full Text] [Related]
22. Possible role of DT-diaphorase in the bioactivation of antitumor quinones.
Talcott RE; Rosenblum M; Levin VA
Biochem Biophys Res Commun; 1983 Feb; 111(1):346-51. PubMed ID: 6187345
[TBL] [Abstract][Full Text] [Related]
23. The enzymology of doxorubicin quinone reduction in tumour tissue.
Cummings J; Allan L; Willmott N; Riley R; Workman P; Smyth JF
Biochem Pharmacol; 1992 Dec; 44(11):2175-83. PubMed ID: 1472082
[TBL] [Abstract][Full Text] [Related]
24. Vitamin K-dependent carboxylation and vitamin K epoxidation. Evidence that the warfarin-sensitive microsomal NAD(P)H dehydrogenase reduces vitamin K1 in these reactions.
Wallin R; Suttie JW
Biochem J; 1981 Mar; 194(3):983-8. PubMed ID: 7306037
[TBL] [Abstract][Full Text] [Related]
25. Rat and human liver vitamin K epoxide reductase: inhibition by thiol blockers and vitamin K1.
Wallin R; Patrick SD; Martin LF
Int J Biochem; 1987; 19(11):1063-8. PubMed ID: 3428478
[TBL] [Abstract][Full Text] [Related]
26. Enzymatic and molecular aspects of the antioxidant effect of menadione in hepatic microsomes.
Tampo Y; Yonaha M
Arch Biochem Biophys; 1996 Oct; 334(1):163-74. PubMed ID: 8837752
[TBL] [Abstract][Full Text] [Related]
27. Vitamin K-dependent carboxylation. Evidence that at least two microsomal dehydrogenases reduce vitamin K1 to support carboxylation.
Wallin R; Hutson S
J Biol Chem; 1982 Feb; 257(4):1583-6. PubMed ID: 6799508
[TBL] [Abstract][Full Text] [Related]
28. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.
Hazelett SE; Preusch PC
Biochem Pharmacol; 1988 Mar; 37(5):929-34. PubMed ID: 3345202
[TBL] [Abstract][Full Text] [Related]
29. Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity.
Shen L; Pisha E; Huang Z; Pezzuto JM; Krol E; Alam Z; van Breemen RB; Bolton JL
Carcinogenesis; 1997 May; 18(5):1093-101. PubMed ID: 9163701
[TBL] [Abstract][Full Text] [Related]
30. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
Fasco MJ; Hildebrandt EF; Suttie JW
J Biol Chem; 1982 Oct; 257(19):11210-2. PubMed ID: 6811577
[TBL] [Abstract][Full Text] [Related]
31. NAD(P)H dehydrogenase and its role in the vitamin K (2-methyl-3-phytyl-1,4-naphthaquinone)-dependent carboxylation reaction.
Wallin R; Gebhardt O; Prydz H
Biochem J; 1978 Jan; 169(1):95-101. PubMed ID: 629756
[TBL] [Abstract][Full Text] [Related]
32. Quinone oxidoreductases and vitamin K metabolism.
Gong X; Gutala R; Jaiswal AK
Vitam Horm; 2008; 78():85-101. PubMed ID: 18374191
[TBL] [Abstract][Full Text] [Related]
33. Structural Insights into Phylloquinone (Vitamin K1), Menaquinone (MK4, MK7), and Menadione (Vitamin K3) Binding to VKORC1.
Chatron N; Hammed A; Benoît E; Lattard V
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609653
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of vitamin K and vitamin K 2,3-epoxide via interaction with a common disulfide.
Lee JJ; Fasco MJ
Biochemistry; 1984 May; 23(10):2246-52. PubMed ID: 6733086
[TBL] [Abstract][Full Text] [Related]
35. On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase.
Segura-Aguilar J; Lind C
Chem Biol Interact; 1989; 72(3):309-24. PubMed ID: 2557982
[TBL] [Abstract][Full Text] [Related]
36. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
Fasco MJ; Principe LM; Walsh WA; Friedman PA
Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
[TBL] [Abstract][Full Text] [Related]
37. Menadione- (2-methyl-1,4-naphthoquinone-) dependent enzymatic redox cycling and calcium release by mitochondria.
Frei B; Winterhalter KH; Richter C
Biochemistry; 1986 Jul; 25(15):4438-43. PubMed ID: 3092856
[TBL] [Abstract][Full Text] [Related]
38. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
Preusch PC; Suttie JW
J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
[TBL] [Abstract][Full Text] [Related]
39. Purification of NADPH-linked and NADH-linked quinone reductases from liver cytosol of sea bream, Pagrus major.
Kitamura S; Tatsumi K
Comp Biochem Physiol B Biochem Mol Biol; 1997 Nov; 118(3):675-80. PubMed ID: 9467879
[TBL] [Abstract][Full Text] [Related]
40. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9.
Walton MI; Smith PJ; Workman P
Cancer Commun; 1991 Jul; 3(7):199-206. PubMed ID: 1714284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
